Claim check · Effectiveness
Humanin and longevity
Claim (representative wording, not a quotation): Humanin extends lifespan.
Plain-English answer
In roundworms, genetically increasing humanin extended lifespan. In mice, a humanin analogue started in middle age did not change survival in the one mouse lifespan test WPF found, though it improved some health measures. In people there are associations and no treatment trial.
Verdict: Overstated. Part of the claim is supported, but the claim says more than the sources show: a wider population, a stronger outcome, a human result from animal work, or a certainty the design cannot give.
What changed?
One change to this record since it was first published; this page shows version 1.6.0. Older versions still resolve.
· Existing source newly verified · Verdict unchanged
Humanin and mouse lifespan: a mouse survival test in an existing paper was newly verified
The verdict stayed Overstated. The earlier version said no mouse lifespan result was found in the abstracts read; checking Figure 3F established that the paper did test mouse lifespan and found no significant difference. That is a null result, which fits an overstated claim. WPF newly verified an experiment that already existed in a paper published in 2020; the paper did not change.
Read this change and its sources · Earlier record (version 1.4.0) · Updated record (version 1.5.0) · Correction Log entry
AI-assisted source verification. Documented human review: none recorded.
Scope
- Population or organism
- C. elegans (lifespan), mice (healthspan measures), humans (blood levels and a gene variant)
- Study design
- Animal and cell experiments, observational human comparisons, and a human genetic-association study
- Boundary
- Lifespan and healthspan. HNG (S14G-humanin) is a laboratory analogue, not the same molecule as natural humanin.
Strongest evidence
The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan (Aging (Albany NY), 2020; PMID 32575074) (Peer-reviewed paper)
Population or organism: C. elegans, humanin-transgenic and middle-aged mice, naked mole-rats, and human blood samples (children of centenarians and controls; disease cohorts)
Design: Transgenic overexpression in worms and mice; twice-weekly HNG in middle-aged mice; observational human comparison of circulating levels
Where in the source: Abstract: overexpression increased worm lifespan in a daf-16/Foxo-dependent way; HNG improved metabolic healthspan parameters and reduced inflammatory markers in mice; humanin levels were higher in children of centenarians. The abstract reports no mouse lifespan extension. Full text read (PMC7343442): female C57BL/6N mice began treatment at 18 months of age (N=100) and were treated for 14 months with the analogue or vehicle; Results, "After 14-months of treatment, there was no significant difference in lifespans between the groups (Figure 3F)"; Figure 3F (survival, percent surviving against age in months) shows the control and treated curves overlapping from about 21 to 33 months; Figure 3G shows lower IGF-I and Figure 3H a trend (p<.1) for lower leptin in the treated group; the authors suggest the lack of a lifespan effect may reflect a sub-optimal dosage or a treatment that started too late.
Humanin-induced autophagy plays important roles in skeletal muscle function and lifespan extension (BBA Gen Subj, 2022; PMID 34624450) (Peer-reviewed paper)
Population or organism: Cell lines, mice, C. elegans and a human cohort
Design: Screening and validation experiments
Where in the source: Abstract: humanin increased autophagy in cells and mouse muscle; autophagy was required for humanin-induced lifespan extension in C. elegans.
Humanin variant P3S is associated with longevity in APOE4 carriers (Aging Cell, 2024; PMID 38520065) (Peer-reviewed paper)
Population or organism: Human centenarians with the APOE4 allele; APP/PS1/APOE4 mice; cell experiments
Design: Human genetic association plus mouse and in vitro experiments
Where in the source: Abstract: the P3S variant was enriched in APOE4-carrying centenarians; in the mouse model it reduced brain amyloid-beta accumulation.
What remains uncertain
- The worm result used genetic overexpression, not a dosed peptide, and worm lifespan does not predict human lifespan.
- Higher humanin in children of centenarians is an association; it does not show that raising humanin lengthens life.
- WPF read the full text of the 2020 Aging paper (PMID 32575074) for the mouse lifespan result; the other two sources were read as abstracts, so their effect sizes and controls are not assessed.
- The mouse lifespan test used one analogue in female mice treated from 18 months; the authors themselves say the absence of an effect may reflect a sub-optimal dosage or a late start, so it does not show that humanin cannot change lifespan in mice.
What would change the answer
- A mouse survival study, replicated by another laboratory, in which humanin or an analogue changes lifespan (the one mouse lifespan test found showed no significant difference).
- A registered human trial that gives humanin or an analogue and reports a clinical aging outcome.
Exact gaps
- No interventional human trial of humanin or an analogue was found. The seven ClinicalTrials.gov registrations that mention humanin are five observational biomarker studies and two interventional trials of exercise and anaesthesia that measure humanin.
- One mouse lifespan result was found (a null result for an analogue started at 18 months in female mice). No mouse lifespan study with earlier treatment, males or another strain was found, but WPF did not read the full texts of the other 18 longevity-related records.
Where WPF looked for missing evidence
Searched on 2026-11-14 in: PubMed; ClinicalTrials.gov API v2.
- PubMed: humanin[tiab] -> 553 records
- PubMed: humanin AND (lifespan OR longevity OR healthspan OR "life span") -> 19 records
- PubMed: humanin AND (lifespan OR "life span") AND (elegans OR mice OR mouse) -> 5 records
- ClinicalTrials.gov: query.term=humanin -> 7 registrations
Found: Worm lifespan extension by overexpression, mouse healthspan measures with an analogue, a null mouse lifespan result for the analogue (full text of PMID 32575074), and human associations. No human treatment trial.
Not searched: Full text of the 19 longevity-related records, except PMID 32575074; Embase; Unpublished or non-English studies.
Not finding evidence in these searches is not proof that none exists.
Date checked and review status
Checked: · version 1.6.0
Review status: AI-assisted source verification. Human review: none recorded. Human review is pending and has not happened.
Related pages
Profiles: /directory/humanin
Cite this check
The citation names the version and an address that keeps returning what was checked, even after a newer version is published.
Humanin and longevity: In roundworms, genetically increasing humanin extended lifespan. In mice, a humanin analogue started in middle age did not change survival in the one mouse lifespan test WPF found, though it improved some health measures. In people there are associations and no treatment trial. Verdict: Overstated. Cited from World Peptide Foundation, Peptide Claims & Evidence, version 1.6.0, claim humanin-extends-lifespan, checked 2026-11-16. AI-assisted source verification; human review none recorded.
Page:
https://www.worldpeptidefoundation.org/research/check/humanin-extends-lifespan
Versioned record:
https://www.worldpeptidefoundation.org/api/research/claims/humanin-extends-lifespan?version=1.6.0
Versioned record: /api/research/claims/humanin-extends-lifespan?version=1.6.0